Patient Assistance Programs for Ocrevus Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. Provider: Patient Access Network Foundation (PAN)
Full Answer
What is Ocrevus co-pay program?
Co-pay programs provide direct financial assistance to patients to help with their co-pays, co-insurance or other out-of-pocket costs. If eligible commercially insured patients need assistance with their out-of-pocket drug and/or infusion costs, your OCREVUS Patient Navigator can help them enroll in the OCREVUS Co-pay Program.
How do I qualify for free Ocrevus If I have insurance?
If you have health insurance for your medicine, you must have already tried other types of patient assistance to qualify for free OCREVUS from the Genentech Patient Foundation. This includes the OCREVUS Co-pay Card and support from independent co-pay assistance foundations. You must also meet financial criteria.
How do I use the Ocrevus patient assistance tool?
Your OCREVUS Patient Navigator can help identify assistance options for eligible patients, or you can use the Patient Assistance Tool below. To use this tool, answer a few simple questions to find out which patient assistance option might be right for your patient. Find the right assistance option for your patients.
What is the Ocrevus patient navigator referral program?
For eligible patients with commercial or public health insurance, your OCREVUS Patient Navigator offers referrals to independent co-pay assistance foundations.† *Eligibility criteria apply.
Does Ocrevus have copay assistance?
OCREVUS Co-pay Program Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs. Patients who qualify can receive up to $21,000 in assistance per 12-month period.
How does the Ocrevus co-pay program work?
The OCREVUS Co-pay Program verifies the patient's information and notifies your practice when the card is loaded with the proper amount. Collect the patient's $5 co-pay for drug costs and/or $5 co-pay for infusion costs, then collect the rest of the patient's out-of-pocket costs for drug and/or infusion using the card.
How long do you stay on Ocrevus?
All participants will take Ocrevus 600mg every 24 weeks by iv infusion for 192 weeks with a follow-up period of at least 48 weeks. The study will monitor a number of measures of MS activity, including disability worsening or improvement, relapses and lesions seen on MRI.
How do you qualify for Ocrevus?
Genentech Patient Foundation *In order to be eligible for the OCREVUS Co-pay Card, the patient must have commercial insurance; must not have Medicare, Medicaid or other government insurance; and must meet other eligibility criteria.
Is there a generic for OCREVUS?
Ocrevus, whose generic name is ocrelizumab, also is approved to treat patients who have relapsing-remitting MS.
Is multiple sclerosis genetic?
your genes – MS isn't directly inherited, but people who are related to someone with the condition are more likely to develop it; the chance of a sibling or child of someone with MS also developing it is estimated to be around 2 to 3 in 100.
Why does Ocrevus cause weight gain?
No, weight gain hasn't been reported as a side effect in people taking Ocrevus. However, in clinical trials, some people taking Ocrevus for primary progressive multiple sclerosis (PPMS) reported swelling in their arms and legs. Sometimes, this swelling can cause weight gain.
How do people feel after Ocrevus infusion?
You may have fatigue (lack of energy) after receiving your Ocrevus infusion. It's likely you'll experience fatigue as an infusion side effect. Aside from lack of energy, other symptoms of fatigue may include: sore muscles.
Can you drink alcohol on Ocrevus?
Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis). Ocrelizumab can make you more likely to get infections or may worsen any current infections.
Can Ocrevus make MS worse?
Ocrevus works by decreasing the number of certain cells in your immune system called B cells. These B cells make your MS symptoms worse.
Does Ocrevus improve walking?
People treated with Ocrevus had a 49% reduction in the risk of needing a walking aid compared to those that received interferon beta-1a over 6 years of study (4.3% vs. 7.2%*; p=0.0042).
Does Ocrevus stop MS?
About OCREVUS It targets a type of immune cell called a CD20-positive B cell that plays a key role in the disease. OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
Does Ocrevus stop MS?
About OCREVUS It targets a type of immune cell called a CD20-positive B cell that plays a key role in the disease. OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
How long is immune system suppressed after Ocrevus?
A: The average half-life of ocrelizumab in the body is approximately 28 days. Following administration, B-cells are rapidly depleted and can remain undetectable for a prolonged and variable period of time ranging from 6 months to more than 12 months.
What are the long term side effects of Ocrevus?
Are there any long-term side effects of Ocrevus? Ocrevus weakens part of your immune system (your body's defense against disease). As a result, Ocrevus can increase your risk for infections. You'll have an increased risk for infections as long as you continue to have Ocrevus treatment.
Does Ocrevus wear off?
Seventy-one (61%) out of 117 participants reported the wearing-off phenomenon during ocrelizumab treatment. The most frequently reported symptoms were fatigue, cognitive disability and sensory symptoms. Wearing-off symptoms started < 1 week (11%), 1–4 weeks (49%) or more than 4 weeks (37%) before ocrelizumab infusion.
When should ocrevus be discontinued?
If serious herpes infections occur, OCREVUS should be discontinued or withheld until the infection has resolved, and appropriate treatment should be administered.
Is there any data on the developmental risk associated with Ocrevus?
There are no adequate data on the developmental risk associated with use of OCREVUS in pregnant women. There are no data on B-cell levels in human neonates following maternal exposure to OCREVUS. However, transient peripheral B-cell depletion and lymphocytopenia have been reported in infants born to mothers exposed to other anti-CD20 antibodies during pregnancy. OCREVUS is a humanized monoclonal antibody of an immunoglobulin G1 subtype and immunoglobulins are known to cross the placental barrier.
Does Ocrevus cause breast cancer?
An increased risk of malignancy with OCREVUS may exist. In controlled trials, malignancies, including breast cancer, occurred more frequently in OCREVUS-treated patients. Breast cancer occurred in 6 of 781 females treated with OCREVUS and none of 668 females treated with REBIF or placebo. Patients should follow standard breast cancer screening guidelines.
Can you use ocrevus after immunosuppressive therapy?
When initiating OCREVUS after an immunosuppressive therapy or initiating an immunosuppressive therapy after OCREVUS, consider the potential for increased immunosuppressive effect. OCREVUS has not been studied in combination with other MS therapies.
Does Ocrevus work for hepatitis B?
Perform HBV screening in all patients before initiation of treatment with OCREVUS. Do not administer OCREVUS to patients with active HBV confirmed by positive results for HBsAg and anti-HB tests. For patients who are negative for surface antigen [HBsAg] and positive for HB core antibody [HBcAb+] or are carriers of HBV [HBsAg+], consult liver disease experts before starting and during treatment.
Can a herpes infection occur with ocrevus?
Serious cases of infections caused by herpes simplex virus and varicella zoster virus, including central nervous system infections (encephalitis and meningitis), intraocular infections, and disseminated skin and soft tissue infections, have been reported in the postmarketing setting in multiple sclerosis patients receiving OCREVUS. Serious herpes virus infections may occur at any time during treatment with OCREVUS. Some cases were life-threatening.
Does ocrevus cause infections?
A higher proportion of OCREVUS- treated patients experienced infections compared to patients taking REBIF or placebo. In RMS trials, 58% of OCREVUS-treated patients experienced one or more infections compared to 52% of REBIF-treated patients. In the PPMS trial, 70% of OCREVUS-treated patients experienced one or more infections compared to 68% of patients on placebo. OCREVUS increased the risk for upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes-related infections. OCREVUS was not associated with an increased risk of serious infections in MS patients. Delay OCREVUS administration in patients with an active infection until the infection is resolved.
Financial Assistance Options
Genentech offers a variety of assistance options for your patients, based on certain eligibility criteria. Use the chart below to determine which assistance program may be right for your patient.
OCREVUS Co-pay Program
Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs.
Genentech Patient Foundation
The Genentech Patient Foundation helps people affected by serious medical conditions get the Genentech medicine they have been prescribed. If patients don’t have insurance coverage or have financial concerns and meet eligibility criteria, they may be able to get free medicine from the Genentech Patient Foundation.
Independent Co-pay Foundations
If eligible publicly or commercially insured patients have difficulty paying for their co-pay, co-insurance, or other out-of-pocket costs, Genentech Access Solutions can refer them to an independent co-pay assistance foundation supporting their diagnosis.
What is the registry for Ocrevus?
Pregnancy Registry. There is a pregnancy registry for women who take OCREVUS during pregnancy. If you become pregnant while receiving OCREVUS, tell your healthcare provider right away. Talk to your healthcare provider about registering with the OCREVUS Pregnancy Registry. The purpose of this registry is to collect information about your health and your baby’s health. Your healthcare provider can enroll you in this registry by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
What to do if you have a baby and you have ocrevus?
If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated. are pregnant, think that you might be pregnant, or plan to become pregnant.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: These infusion reactions can happen for up to 24 hours after your infusion.
How long after birth control can you use ocrevus?
It is not known if OCREVUS will harm your unborn baby. You should use birth control (contraception) during treatment with OCREVUS and for 6 months after your last infusion of OCREVUS. Talk with your healthcare provider about what birth control method is right for you during this time. Pregnancy Registry.
When should you get your Ocrevus shots?
When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with OCREVUS. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with OCREVUS, talk to your healthcare provider.
Does Ocrevus slow down the rate of infusion?
If you get infusion reactions, your healthcare provider may need to stop or slow down the rate of your infusion. Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections.
Can you take ocrevus if you are allergic to it?
Do not receive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
The OCREVUS Co-pay Program
Your Patient Navigator can help eligible commercially insured patients enroll in the OCREVUS Co-pay Program for help with their out-of-pocket drug costs, infusion costs or both.*
Referrals to Independent Co-pay Assistance Foundations
For eligible patients with commercial or public health insurance, your OCREVUS Patient Navigator offers referrals to independent co-pay assistance foundations.†
How to contact Ocrevus?
For more information, go to www.OCREVUS.comor call 1-844-627-3887.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.
Is ocrevus safe for children?
Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
Can you delay treatment with ocrevus?
Your healthcare provider should delay your treatment with OCREVUS until your infection is gone. Decreased immunoglobulins: OCREVUS may cause a decrease in some types of immunoglobulins. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Who owns the OCREVUS logo?
OCREVUS®and its logo are registered trademarks of Genentech, Inc.
Does ocrevus cause skin infections?
Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Infections are a common side effect, which can be serious. Tell your healthcare provider right away if you have an infection.
How to contact Ocrevus?
For more information, go to www.OCREVUS.com or call 1-844-627-3887.
What is ocrevus used for?
What is OCREVUS? OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
What is the most important information I should know about OCREVUS?
Infusion reactions: Infusion reactions are a common side effect of OCREVUS, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.
Can you delay treatment with ocrevus?
Your healthcare provider should delay your treatment with OCREVUS until your infection is gone. Decreased immunoglobulins: OCREVUS may cause a decrease in some types of immunoglobulins. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Does ocrevus cause skin infections?
Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Infections are a common side effect, which can be serious. Tell your healthcare provider right away if you have an infection.
Does ocrevus cause cancer?
OCREVUS may cause serious side effects, including: Risk of cancers (malignancies) including breast cancer. Follow your healthcare provider’s instructions about standard screening guidelines for breast cancer. These are not all the possible side effects of OCREVUS. Call your doctor for medical advice about side effects.